Skip to main content

Cosmetics Europe Science Conference

26 - 27 October 2017

Registrations are closed


Learn about the Cosmetics Europe Science programme and discuss the industry’s achievements.

Challenge tomorrow’s research and be introduced to hot topics that will shape the future.

Are you keen to know about consumer exposure?
There will be a dedicated session on the latest advances.

Are you interested in safety assessment?
Top scientists will reveal novel approaches and regulators will explore the potential impacts.

Do you want to hear the latest developments in Alternatives to Animal Testing (AAT) research programmes? Come and listen to the most recent developments in ongoing European and international research programmes.

  • Join 150 top scientists, industry experts, key decision makers and regulatory specialists. There will be keynote speeches and breakout sessions.
  • Discuss uncertainties in research and see how they can be transformed into new business opportunities.
  • Gain insight into tomorrow’s technologies and see how they could be applied in your work.
  • You will be able to watch researchers present their posters. There will be an award for the best poster.




Start: 26 October 2017
End: 27 October 2017
Cosmetics Europe

Hotel BLOOM!

Rue Royale 250
1210 Saint-Josse-ten-Noode Bruxelles

Related documents

  • terms-and-conditions-science-conference.pdf
  • science-conference-programme.pdf
  • ce-2017-china-2.png
  • abstract-toxys-toxtracker-2017-2.png


Dr Rob Taalman

Director Science and Research
Cosmetics Europe
  • Dr Rob Taalman

    Rob received a degree in Cell biology and a PhD in Human Genetics and Pediatrics from the University of Nijmegen (The Netherlands) in 1987. Prior to Cosmetics Europe, Rob worked for Litton Bionetics (US), Hazleton Biotechnologies (UK & NL) and the Dutch National Health & Environment Institute (RIVM). In 1992 he joined Shell International in the Hague as a toxicologist and HSE advisor, moved to Shell Chemicals in London.In 1997 he was seconded to the European Chemical Industry Council (Cefic) where he was responsible for all Research & Science activities undertaking jointly by the European Chemical Industry. In May 2003 he returned to Shell Chemicals to take up the position of corporate HSE manager. In 2005, he relocated to Shell International in the Hague as the Group’s senior Environmental Health manager. Rob joined Cosmetics Europe in January 2010.

    Read more

Dr Kirsty Reid

  • Dr Kirsty Reid

    Kirsty Reid is manager for science policy and animal welfare at EFPIA, the European Federation of Pharmaceutical Industry and associations. She has a scientific background with a PhD in Biology and has worked in the EU regulatory and public affairs for the past 12 years with specific focus on EU animal experimentation legislation, animal welfare and alternatives to animals arena across several sectors.

    Read more

Dr Horst Wenck

Corporate Vice President of Front End Innovation
  • Dr Horst Wenck

    Horst Wenck is Corporate Vice President of Front End Innovation at Beiersdorf AG, Hamburg, Germany. He is responsible for a portfolio of internal projects and external co-operations to secure the mid to long term pipeline of the company’s consumer products. This comprises fields from biology, development of actives to biophysics and fundamental formulation technologies.

    During his three decades in industrial R&D, Horst Wenck has managed several international product and technology and packaging development as well as testing organizations, with a main focus on making early innovation most impactful for the business.

    Horst Wenck is a member of the American Academy of Dermatology, the Society for Investigative Dermatology and the chairman of both the Cosmetics Europe Strategic Core Team on Alternatives to Animal Testing (SCT AAT) and the Cosmetics Europe Long Range Science Strategy Consortium. As such he is responsible for directing the major program of the European Cosmetic Industry that aims at developing 21st Century Toxicology comprising novel test methods and strategies to conduct safety assessment of cosmetic ingredients without any traditional animal tests.

    Read more

Prof Dr Bob Van de Water

Professor Drug Safety Sciences
Leiden University, EuToxRisk
  • Prof Dr Bob Van de Water

    Bob van de Water (Leiden University) received his PhD from Leiden University in 1995. Since 2006 he is professor Drug Safety Sciences at the Leiden Academic Centre for Drug Research and heads the Research Cluster Drug Discovery and Safety. His research is focused on the mechanistic uncovering of adverse drug reactions through the application of omics approaches with a focus on liver and kidney toxicity. The molecular insights are used to establish fluorescent reporter cell models for 2D and 3D application to quantitatively monitor adverse drug action using automated live cell microscopy; these data are integrated in quantitative systems biology modelling approaches for safety testing. He is coordinator of the H2020 EU-ToxRisk project, a European flagship project for alternative-to-animal testing strategies for quantitative human chemical safety assessment and partner in the Innovative Medicine Initiative projects TransQST and eTRANSAFE. He also leads the Eu-BioImaging Dutch High Throughput Microscopy Node, a screening facility for systematic imaging-based automated quantitative cell biological 2D and 3D phenotyping.

    Read more

Dr Boris Müller

Vice President Global Strategic Regulatory Affairs S&C
EPAA, Symrise
  • Dr Boris Müller

    Boris Müller, Vice President Global Strategic Regulatory Affairs Scent&Care, works for Symrise AG, a global fragrance, flavour, and cosmetic ingredient manufacturer with its headquarters in Germany. Having shaped the product safety group within Symrise to cope with new challenges, e.g. REACH, Boris now focuses on regulatory & safety topics within the fragrance associations, namely IFRA (the International Fragrance Association) and RIFM (Research Institute for Fragrance Materials). Another topic particularly close to his heart and professional interest is the area of alternative methods to animal testing. This is also reflected in Symrise’s membership of EPAA (European Partnership for Alternative Approaches to Animal Testing). Boris is a biologist/toxicologist by training and prior to fragrances, he has worked on cosmetics, tobacco smoke, medical devices, and pesticides in his career.

    Read more

Prof Dr Bette Meek

Associate Director, Chemical Risk Assessment
McLaughlin Centre for Risk Science
University of Ottawa
  • Prof Dr Bette Meek

    Dr. Meek is currently the Associate Director of Chemical Risk Assessment at the McLaughlin Centre for Risk Science, University of Ottawa. She previously managed several chemical risk assessment programs within Health Canada. With colleagues internationally, she has contributed to or led initiatives in areas such as weight of evidence analysis for mode of action, chemical specific adjustment factors, physiologically-based pharmacokinetic modeling, combined exposures and predictive modeling. She has authored over 175 publications in this area and received several awards for contribution in this domain. Dr. Meek has a background in toxicology receiving her M.Sc. in Toxicology (with distinction) from the University of Surrey and her Ph.D. in risk assessment from the University of Utrecht.

    Read more

Dr Sarah Tozer

Procter & Gamble
  • Dr Sarah Tozer

    Dr. Sarah Tozer received her her Ph.D. in Neuropharmacology and Neurotoxicology from King’s College London and now has over 17 years’ experience in toxicological evaluation and risk assessment in Industry. Sarah has much experience in the exposure assessment of chemicals in consumer products, and leads exposure modelling work at Procter & Gamble, with a keen interest in further developing exposure based risk assessment as an integral part of safety assessment. Externally, Sarah is chair of Cosmetics Europe Exposure Task force and co-chair in the ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) Human Exposure Task Force.

    Read more

Prof Alistair Boxall

Professor in Environmental Science
University of York
  • Prof Alistair Boxall

    Alistair Boxall is Professor in Environmental Science in the Environment Department at the University of York. Alistair’s research focuses on understanding emerging and future ecological and health risks posed by chemical contaminants in the natural environment. Alistair is a past member of the Defra Hazardous Substances Advisory Committee and the Veterinary Products Committee. He is Co-ordinator of the 3.5 M Euro CAPACITIE project on pollution monitoring in cities; academic co-ordinator of the 10.3 M Euro iPiE project on intelligence-led assessment of pharmaceuticals in the environment; and leads the York City Environment Observatory initiative. He regularly advises national and international organisations on issues relating to chemical impacts on the environment and has published extensively on the topic of chemical risks in the environment.

    Read more

Dr Helga Rothe

Senior Toxicologist, with global responsibility for the human safety support of cosmetic hair products and a number of key raw materials
  • Dr Helga Rothe

    Dr. Helga Rothe holds a Diploma and Doctorate degrees in Chemistry, is Associated Professor for Immunology and Cellular Biology and did research on the immuno-pathogenesis of type 1 diabetes at the Universities of Düsseldorf and Munich, before she started in Product Development at Wella AG as head of the Biotechnology Department in 2001. Since the merger with Procter and Gamble in 2003 and after the merger with Coty in 2016, Dr. Rothe works as a Senior Toxicologist, with global responsibility for the human safety support of cosmetic hair products and a number of key raw materials. In this context she is responsible for developing and executing safety programs to support ingredients of interest to the company, toxicological dossier compilation for chemical registration etc..

    As the company´s expert for skin penetration, ADME and inhalation her key technical responsibility is the development of new exposure assessment strategies and animal alternative in vitro/in silico methods for future toxicology risk assessments. Throughout her career she worked in a number European trade association task forces (Cosmetics Europe, ILSI, FEA) and chaired international industry association teams at Cosmetics Europe (CE) and European Aerosol Federation (FEA). She currently is member of the ADME TaskForce and co-chair of the Inhalation Exposure Team at CE.

    Dr. Rothe´s scientific contributions were published in more than 45 peer-reviewed articles in scientific journals and in over 80 presentations at international congresses. Since 2009 she is an instructor at the Regulatory Toxicology of Cosmetics course of the German Society of Experimental and Clinical Pharmacology and Toxicology (DGPT).

    Read more

Prof Dr Vera Rogiers

Vice–Chair of the SCCS and Professor of Toxicology, Vrije Universiteit Brussel
SCCS, Vrije Universiteit Brussel
  • Prof Dr Vera Rogiers

    Vera Rogiers is full-time professor of Toxicology at the VUB and organizes international courses on Cosmetics and Risk Assessment. Her main research activity is situated in experimental toxicology, in the development of in vitro models as an alternative to the use of experimental animals. Actual focus is on the differentiation of human skin-derived stem cells to functional hepatic cells and their application for drug discovery and the detection of drug-induced liver injury. She has been promoter of 28 doctoral theses, is author of >320 publications in international journals and is editor of several scientific books. She is an often invited speaker and participated in the organization of 60 international congresses. She has coordinated 2 EU research projects and was partner in several FP6 and FP7 EU projects concerned with in vitro methodology development. Of the obtained scientific results, several patents have been filed. She has obtained international scientific awards, in particular for her pioneering role in in vitro experimental toxicology

    Read more

Dr George Daston

Victor Mills Society Research Fellow
Procter & Gamble
  • Dr George Daston

    George Daston is Victor Mills Society Research Fellow at the Procter & Gamble Company, the highest scientific rank achievable. He has published over 100 articles and book chapters and edited five books in toxicology and risk assessment. His most cited work is on the topics of mechanistic approaches to characterize dose-response and risk from estrogenic chemicals, the role of toxicity-induced micronutrient deficiencies in developmental toxicity, and identifying that the triazines melamine and cyanuric acid were responsible for an epidemic of acute renal failure in dogs and cats in North America, and later in babies in China. His current research efforts are in the areas of cheminformatics, toxicogenomics and predictive and mechanistic toxicology, particularly in addressing how findings in these fields can improve risk assessment for chemicals and the development of non-animal alternatives. Dr. Daston has served as President of the Teratology Society, Councilor and Treasurer of the Society of Toxicology, on the USEPA’s Science Advisory Board, Board of Scientific Counselors and Endocrine Disrupter Screening and Testing Advisory Committee, National Toxicology Program Board of Scientific Counselors, National Research Council’s Board of Environmental Studies and Toxicology, and National Children’s Study Advisory Committee. In his advisory role at EPA, he oversaw the chartering and first five years of EPA’s acclaimed Computational Toxicology Program. He is Editor-in-Chief of Birth Defects Research: Developmental and Reproductive Toxicology. With scientists at the Humane Society of the US, Dr. Daston manages the AltTox website, which is devoted to the exchange of scientific information leading to the development of non-animal replacements for toxicity assessments. Dr. Daston has been awarded the Josef Warkany Lectureship and the Distinguished Service Award by the Teratology Society, the George H. Scott Award by the Toxicology Forum, the Society of Toxicology’s Best Paper of the Year Award, and is an elected Fellow of AAAS. Dr. Daston is an adjunct Professor of Pediatrics at University of Cincinnati.

    Read more

Prof Dr Mark Cronin

Professor of Predictive Toxicology
School of Pharmacy and Biomolecular Sciences, John Moores Liverpool University
Prof Dr Mark Cronin
  • Prof Dr Mark Cronin

    Mark Cronin is Professor of Predictive Toxicology in the School of Pharmacy and Biomolecular Sciences at Liverpool John Moores University, England. He has over 25 years expertise in the development of in silico alternatives for toxicity testing. In his career Cronin has enjoyed developing computational models, such as Quantitative Structure-Activity Relationships (QSARS) for toxicity endpoints as diverse as skin sensitisation, and repeated dose affects and acute environmental toxicity, taking them from an academic interest to being used by many industries and government agencies. More recently he developed a number of read-across strategies and case studies for complex toxicities, especially focusing on issues relating to cosmetics ingredients, through the European Union / Cosmetics Europe COSMOS Project which he co-ordinated. Mark Cronin has published over 250 peer-reviewed journal articles and four books as well as having been privileged to speak to many audiences and work on international projects.

    Read more

Dr Robert Landsiedel

Vice President of an experimental toxicology unit
  • Dr Robert Landsiedel

    Dr. Robert Landsiedel earned a Ph.D. in chemistry and a postgraduate degree in toxicology. After a postdoc position at the toxicology department of the German institute of human nutrition in Potsdam, he started working for BASF in 1999. After assignments in product development and product safety in North Carolina, USA and Tokyo, Japan, he returned to Ludwigshafen, Germany in 2006.

    He is now Vice President of an experimental toxicology unit. His team is performing more than 500 toxicological studies per year for regulatory and screening purposes. Moreover, they are developing new methods in toxicology and performing research on the safety of nanomaterials. His team has participated in more than 10 publicly-funded research projects and published more than 100 scientific papers.

    In 2012 they received the BASF Innovation Award and in 2013 the Research Award of the state of Rhineland-Palatinate as well as the German Federal Research Award for the development of alternative methods; in 2016 Robert received the German Toxicology Award.

    He is Vice-president of the German Society of Toxicology and member of the Scientific Committee on Occupational Exposure Limits (SCOEL) of the EU Commission; he lectures toxicology at the universities of Koblenz-Landau and Leipzig as well as Freie Universität Berlin.

    Read more

Dr Martin Paparella

Austrian National Coordinator of Testing Methods for OECD WNT and PARERE
Environment Agency Austria, Vienna
  • Dr Martin Paparella

    Dr. Martin Paparella, MAS(Tox)

    European Registered Toxicologist (ERT)

    Function: National Coordinator of Testing Methods for OECD WNT, for the European Testing Methods Regulation and PARERE; OECD WNT Vice chair; regulatory toxicologist for classification and risk assessment of biocides and chemicals.

    Work place: Environment Agency Austria, Vienna

    Expertise: Studies of Biotechnology at the University of Agriculture (BOKU, Vienna, phD) and Toxicology at the Medical University in Vienna (MAS). 8 years of experience with the development and validation of toxicological in vitro methods, 3 of these years at the BOKU, 5 years at ECVAM (European Centre for the Validation of Alternative Methods, Joint Research Centre, Italy). After this 13 years of experience as regulatory toxicologist: Human health risk assessment of biocides for European regulatory processes, active participation in European Biocides Technical Meetings and related subgroups. Classification and toxicological hazard/risk evaluations in the REACH context. Lecturing and training in the field of human regulatory toxicology, e.g. at the Medical University Vienna, University of Applied Sciences Technikum Vienna and within European Twinning Projects. OECD WNT Vice Chair (2015-2018), Austrian National Coordinator of Testing Methods for OECD WNT (since 2014) and for the European Testing Methods Regulation and PARERE (preliminary assessment of regulatory relevance of new alternative methods, both since 2011), active contributions in this field of regulatory testing methods within related international working groups, with a focus on alternative approaches, specific interest in systematic uncertainty analysis of animal reference test data, see e.g.
    Read more

Dr Bertrand Desprez

LRSS Project Manager
Cosmetics Europe
  • Dr Bertrand Desprez
    Bertrand received a Doctorate in Pharmacy (thesis on Segetalins cyclopeptides) and a Master of Public Health degree (thesis on endocrine disruptors risk assessment) with a specialisation in quantitative risk assessment. He was previously working for the OECD and EURL ECVAM on the evaluation and regulatory acceptance of alternative (non-animal) methods. He works now in Cosmetics Europe Science & Research Department, as research project manager, and focuses on the Long Range Science Strategy programme in systemic toxicity, ocular toxicity and genotoxicity.
    Read more

Dr Ellen Mihaich

CEO of Environmental and Regulatory Resources
Dr Ellen Mihaich
  • Dr Ellen Mihaich

    Dr. Ellen Mihaich is currently the owner and principal scientist of Environmental and Regulatory Resources, LLC, specializing in environmental toxicology, risk assessment, and regulatory services. She is also an Adjunct Professor at Duke University, where she teaches a graduate level course in risk assessment. She is the scientific coordinator of the Endocrine Policy Forum, a representative to the OECD Ecological Validation Management Group and has participated in many expert panels globally, developing endocrine testing guidelines. She received a B.A. from Wellesley College and M.S./Ph.D. degrees in environmental toxicology from Duke University. She is a past president of SETAC and a board-certified toxicologist. Dr. Mihaich has authored or coauthored more than 40 publications in peer-reviewed journals or government publications.

    Read more

Prof Dr Aldert H.Piersma

Professor of reproductive toxicology at the Institute for Risk Assessment Sciences (IRAS) of Utrecht University in the Netherlands , senior scientist at the National Institute for Public Health and the Environment (RIVM)
RIVM and Utrecht University
  • Prof Dr Aldert H.Piersma

    Aldert H. Piersma Ph.D. is a professor of reproductive toxicology at the Institute for Risk Assessment Sciences (IRAS) of Utrecht University in the Netherlands since 2007, and is employed as a senior scientist at the National Institute for Public Health and the Environment (RIVM) in the Netherlands since 1988.

    His work combines fundamental research in reproductive toxicology with advisory work in national and international advisory committees, such as of the Dutch Health Council, EU, OECD and WHO. Main theme is the innovation of hazard and risk assessment methodology in reproductive and developmental toxicology, including the design and implementation of animal-free alternative methods and molecular approaches towards mechanism of action based understanding of toxicity. He is known for his work on alternatives to animal testing in developmental toxicology, using animal-free assays with embryonic stem cell lines, as well as zebrafish and rat embryos. He applies molecular approaches to understand mechanisms of action and to identify adverse outcome pathways, facilitating the understanding and implementation of alternative methods. He also invests in the design of alternative testing strategies, combining assays to enhance the prediction of developmental toxicity and to reduce and replace animal use in chemical and pharmaceutical risk assessment. He published over 150 original scientific papers, over 200 abstracts and around 10 book chapters. His H-index is 34. He is associate editor of Reproductive Toxicology.

    Read more

Dr Sylvain Bougoin

Project Manager
Cosmetics Europe
  • Dr Sylvain Bougoin

    Sylvain received a Master degree in Cellular Biology and Physiology and a PhD in Cell Signalling and Molecular interactions from the University of Tours (France) in 2007. Following his PhD, Sylvain did various postdoc studies in France and in Pittsburgh, USA, and published scientific articles in international journals. From March 2014 to September 2015, after he relocated to Norway, Sylvain worked first as a Research Scientist for Polypure AS and later as a Project leader for Spermatech AS, both biotechnology companies. Prior to joining Cosmetics Europe in 2017, Sylvain was a Senior Regulatory Affairs Specialist for Laerdal Medical, world leading provider of training, educational and therapy products for lifesaving.

    Read more

Dr Bart van der Burg

Chief Scientific Officer and Director of Innovation
  • Dr Bart van der Burg

    Bart van der Burg got his PhD at the Faculty of Biology of the Utrecht University. Until 2002 he was a senior scientific staff member at the Hubrecht Institute of the Royal Netherlands Academy of Sciences in Utrecht, after which he joined BioDetection Systems (BDS) as a Chief Scientific Officer and subsequently Director of Innovation. Much of his career has been focussed on studying the mode of action of toxicants, with a focus on endocrine active and reproductive toxicants, with the aim to design specific bioassays for hazard identification of single compounds and complex mixtures. Since the same mechanisms are often targeted by toxicants in the human body, the assays are not confined to reproductive toxicity alone, but find their way in other areas as well, such as mutagenesis and carcinogenesis. Bart has ample experience in open innovation and as a leader of academic and industrial research groups of varying composition and has been coordinator of various large-scale collaborative research projects, including the FP7 ChemScreen project on integrated testing methods for reproductive toxicants. He is also a member of the EU-ToxRisk Steering Team, and a workpackage leader.

    Read more

Dr Gladys Ouédraogo

Scientific Officer, Predictive model and method development department
  • Dr Gladys Ouédraogo

    Over 18 years’ experience in developing predictive methods for toxicity.

    Main achievements in the areas of genetic toxicity and cancer, systemic toxicity


    Sept 2013 – present: L’Oréal Research & Innovation, Predictive models and methods development Department; Aulnay sous bois - France. Scientific Officer: leads research collaboration with external partners mainly on repeated dose systemic toxicity and genotoxicity. Representative of the company in different working groups at Cosmetics Europe, EU-ToxRisk, OECD, ILSI/HESI.

    Jul 2010 – Aug 2013: L’Oréal Research & Innovation, Predictive models and methods development Department; Aulnay sous bois - France. Head of the predictive methods development group. Managed a team of scientists working on different endpoints like skin sensitization, systemic toxicity, phototoxicity, genotoxicity.

    Apr 2006 – Jun 2010: L’Oréal advanced research, Safety Research Department; Aulnay sous bois – France. Head of the Genotoxicity and Cancer group. Lead several projects on in vitro genotoxicity and in silico approaches (covering different endpoints).

    Mar 2003 -Mar 2006: L’Oreal advanced research, Safety Research Department; Aulnay sous bois - France. Joined the Genotoxicity laboratory, developed in vitro genotoxicity and in vitro cell transformation assays.

    Professional committees: ILSI-HESI (Genetic Toxicology Technical Committee), Cosmetics Europe (Genotoxicity taskforce, Systemic toxicity taskforce), OECD (Extended Advisory Group on Molecular Screening and Toxicogenomics), HTPC (Humane Toxicology Project Consortium), Toxicology Education Foundation (board member since 2014).

    Read more

Dr Dirk Petersohn

Director Biological & Clinical Research
  • Dr Dirk Petersohn

    Academic Education and Present Professional Position:

    Since 10/1998

    Henkel AG & Co. KGaA

    Diverse managerial functions in:

    Current position:

    Director Biological & Clinical Research

    Productdevelopment Beauty Care

    Phenion GmbH & Co. KG

    Corporate CentralResearch



    Clinic and Policlinic for

    Dermatology (Medical Department Universitiy of Cologne)

    Post-Doc in the research team “Wound healing”

    of Prof. Dr. Thomas Krieg

    1993 – 1996

    University of Cologne,

    Institute of Genetics

    PhD-Studieson tissue specific gene regulation in

    the human central nervous system.

    Member of the research team of Prof. Dr. G. Thiel

    1988 – 1993

    University of Cologne

    Studies of Biology, Diploma

    Three major fields of activities in current position:

    1. Clinical Studies / volunteer studies to support claims and to proof dermatological compatibility of Henkel products

    2. Basic research on skin, hair and oral cavity.

    Development of 3D engineered tissues to assess bio-actives for cosmetics

    3. Development of regulatory accepted alternatives to animal testing

    Read more

Karolina Brzuska

Issue Manager
Cosmetics Europe

Dr Winfried Steiling

Senior Toxicologist in the Department of Corporate Product Safety
  • Dr Winfried Steiling

    Dr. Winfried Steiling (Diploma of Biochemistry, EUROTOX reg. toxicologist) is working for Henkel since 1989. Since 2004 his position at Henkel is Senior Toxicologist in the Department of Corporate Product Safety (Toxicology). His responsibility is the safety evaluation of consumer products and cosmetic ingredients in particular of Henkel-Schwarzkopf cosmetic products.

    During his long term membership in several TFs and ETs at ECETOC and COLIPA/CE, dealing with standard toxicological test methods and alternatives to animal testing, he was able to develop special expertise in safety assessment of chemical substances, in particular of cosmetic ingredients.

    The monitoring of hundreds of regulatory required toxicological experimental studies, including longterm studies during the last three decades is the ground for his expertise and experience in toxicology testing systems.

    Regular presentations to the EU-scientific expert team for consumer safety (SCCS) in Brussels and lectures in toxicology at the University of Brussels and some German universities since about 20 years emphasize his expertise in the toxicological arena.

    About 40 presentations at international congresses, more than 50 articles in international peer-reviewed journals and book chapters, focusing on inhalation, local irritation, skin sensitization, phototoxicity and percutaneous penetration display his scientific work.

    Read more

Dr Tanja Hansen

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM
  • Dr Tanja Hansen

    Dr. Tanja Hansen

    Dr Tanja Hansen is a member of academic stuff at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM since 1998 and has long-standing experience in toxicity studies with a focus on the development and validation of cellular in-vitro models. Fraunhofer ITEM is offering research services in the fields of occupational and environmental toxicology and consumer protection as well as pre-clinical and clinical drug research and development. A focus is on airborne substances and uptake by inhalation is of particular interest in this context. Tanja has a background in veterinary medicine receiving her degree in 1994 and her doctor’s degree in 1998 from the University of Veterinary Medicine in Hannover. She is a veterinary specialist in pharmacology and toxicology.

    Read more

Dr Veronika Oudova

Co-founder and Chief Executive Officer
  • Dr Veronika Oudova

    Veronika is a co-founder and Chief Executive Officer of S-Biomedic brigning novel therapeutic solutions to the skin microbiome. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industry.

    Read more

Ms Arti Nokhai

Account Manager
  • Ms Arti Nokhai

    Arti Nokhai has a back ground in IT and Business Administration and specializes in Artificial Intelligence. She helps clients to implement innovation, guide the customer understand the value of co-creation within their own organization and beyond. To thrive in this digital economy IT and Business need to work closely together to proactively discover what technology will enable the digital transformation, to gain competitive advantage, maximize value and reduce costs. She strongly believes that by the year 2022 AI will be in the lives of billions of people. The technology keeps evolving and you need to stay on top of your game. "A vision without execution remains an illusion".

    Read more

Dr Joost Vos

Director of TXT INSIGHT
  • Dr Joost Vos

    Joost B. Vos, Ph.D., is director of TXT INSIGHT, an information technology company focusing on the large scale analysis of biomedical text sources. Text data contains a wealth of information, yet it is difficult to extract that information using computers since the text is unstructured. TXT INSIGHT uses IBM Watson’s natural language processing technology for the analysis and interpretation of analyzed text data sources. TXT INSIGHT structures the unstructered.

    Joost obtained a M.Sc. degree in Biomedical Sciences from Utrecht University, Utrecht, The Netherlands and holds a Ph.D in Medicine from the Leiden University Medical Center, Leiden, The Netherlands. Joost was trained as an immuno(toxico)logist and molecular cell biologist. His interest in data science was ignited in the early 2000s while performing his PhD research on the human immune system using genomics technologies. As early data science technology adopter, Joost specialized in developing and adopting large-scale analytics pipelines for analyzing structured as well as unstructured data sources. Joost gained extensive experience in academia life sciences companies, ranging from drug development to pre-clinical safety and efficacy testing. He (co-)authored 12 peer-reviewed scientific publications.

    Read more

Ms Anastasia Georgievskaya

Co-founder and General Manager
Youth Laboratories, and Beauty.AI, RYNKL
  • Ms Anastasia Georgievskaya

    Anastasia Georgievskaya is the co-founder and general manager at Youth Laboratories, a company developing tools to study aging and discover effective anti-aging interventions using advances in machine vision and artificial intelligence. The big goal of Youth Laboratories is to use the facial imaging data to predict the health status of the patient and to keep the patient healthy and young as long as possible.

    She helped organize the first beauty competition judged by the robot jury, Beauty.AI and develop an app for tracking age-related facial changes and testing the effectiveness of various treatments called RYNKL. Anastasia has a degree in bioengineering and bioinformatics from the Moscow State University. She won numerous math and bioinformatics competitions and successfully volunteered for some of the most prestigious companies in aging research including Insilico Medicine.

    Read more

Dr Reyk Horland

Head of Business Development
  • Dr Reyk Horland

    Since 2010 Reyk is actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. He currently holds the position of Head of Business Development at TissUse. Prior to TissUse Reyk studied Biotechnology at the Technische Universität Berlin and specialized in Medical Biotechnology. During his academic career, he was involved in various tissue-engineering programs, all with a focus on bringing the respective products to market.

    Read more

Prof Dr Maurice Whelan

Head of the Chemical Safety and Alternative Methods Unit of the Directorate for Health, Consumers and Reference Materials of JRC
European Commission , Joint Research Centre
  • Prof Dr Maurice Whelan

    Prof. Maurice Whelan is head of the Chemical Safety and Alternative Methods Unit of the Directorate for Health, Consumers and Reference Materials of the European Commission's Joint Research Centre (JRC), based in Ispra, Italy. He also heads the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) of the JRC, established under EU Directive 2010/63 on the protection of animals used for scientific purposes, which builds on the 20 years of activities of ECVAM, the European Centre for the Validation of Alternative Methods. Priorities of his work include the development, validation and promotion of alternative approaches to animal testing both for regulatory safety assessment of chemicals and for applications in biomedical research. Whelan is the EU co-chair of the OECD Advisory Group on Molecular Screening and Toxicogenomics that is responsible for the OECD programme on Adverse Outcome Pathways, and he is a member of the Steering Committee of the European Partnership for Alternative Approaches to Animal Testing (EPAA).

    Read more

Dr Elisabet Berggren

Deputy Head of Unit of the Chemicals Safety & Alternative Methods Unit
European Commission Joint Research Centre
  • Dr Elisabet Berggren

    Elisabet Berggren is Deputy Head of Unit of the Chemicals Safety & Alternative Methods Unit (F.3), which is hosting the European Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM). The activities of the Unit are primarily focussed on the development of a more efficient safety assessment of chemicals based on new approach methods. The aim is to develop new predictive methodologies more relevant to human health, encouraging innovation and avoiding animal testing. Prior to her current position Elisabet was responsible for the Technical Committee of Classification and Labelling of Dangerous Chemicals at the European Chemicals Bureau during many years. Since she started to work for the European Commission in 1996, Elisabet has successfully provided scientific support to EU policy, through her involvement in the development and EU implementation of the Rotterdam Convention and Globally Harmonised System of classification and labelling, and more recently to bridge basic research to regulatory acceptance of new approaches to safety assessment.

    Elisabet made her PhD in physical chemistry at Stockholm's University in 1991. Thereafter she worked with basic research at Bologna University and Lund University. In her academic career she primarily focussed on the development of theoretical dynamic models for liquid crystals and biological relevant systems.

    Read more

Mr John Chave

General Director
Cosmetics Europe


Media Partners

CosmeticOBS-L’Observatoire des Cosmétiques

  • CosmeticOBS-L’Observatoire des Cosmétiques

    Launched in 2008, CosmeticOBS-L'Observatoire des Cosmétiques is the first leading French-based independent media for the cosmetic industry, offering the largest cosmetic products and ingredients data base. Our expert recommend more than 1600 cosmetic brands and 9000 cosmetic products are under evaluation.

    CosmeticObs reports on convention and specialized events in France and abroad, and on market trends and news (regulation, packaging, digital beauty...).

    Read more

Premium Beauty News

  • Premium Beauty News

    Premium Beauty News provides information in English and French to the cosmetics, beauty and personal care industry worldwide and covers the entire personal care sector, from suppliers (ingredients, packaging) to retailers, through brands, with a special focus on products and innovations from the industry's suppliers (ingredients, raw materials, packaging, fill-in, private labeling, design), as well as regulatory news, scientific breakthroughs and latest market trends and key market figures.

    Read more

Chemical Watch

  • Chemical Watch

    Chemical Watch provides the global business community with the facts and perspectives it needs to achieve safer chemicals in products.

    We provide a 360 degree view of this agenda, impartially reporting on the actions and opinions of all stakeholders in our community. Our company has a strong shared sense of purpose, fuelled by motivated staff who want to make a difference with their work.

    Read more

Poster Session

  • Share your poster(s), there will be several occasions to show your recent scientific achievements, make sure you promote your work!
  • This poster session is also a good way to show where you are and what you are planning with your research, and get feedback from top scientists.
  • Be awarded for your poster(s) & gain visibility !
  • The top 3 winning posters will be chosen by a selection panel and poster authors will have the opportunity to present their research in the plenary session.
  • Prize for the 3 winners is a voucher to attend a scientific conference of your choice.